Shanghai Wd Pharmaceutical Co., Ltd.

This early-stage study is testing a tablet called WD-1603, which contains two drugs used for Parkinson's disease (levodopa and carbidopa). The goal is to see how changing the time between doses affects how the drug moves through the body. Twelve healthy adults will take the table…